Skip to main content
Jane Meisel, MD, Oncology, Atlanta, GA

Jane Lowe Meisel MD

Oncology•Atlanta, GA

Breast Cancer, Gynecologic Cancer

Assistant Professor of Medicine, Winship Cancer Institute at Emory University

Join to View Full Profile

  • 1365 Clifton Road NEC2122Atlanta, GA 30322

Dr. Meisel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Meisel's Full ProfileAlready have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011
  • Harvard Medical School
    Harvard Medical SchoolClass of 2008

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2014 - 2026
  • NY State Medical License
    NY State Medical License 2011 - 2015
  • MA State Medical License
    MA State Medical License 2010 - 2013
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Creating Connections and Building Community: Social Media and Physician Quality of Life 
    ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
  • The Continuing Evolution of Targeted Therapy in Breast Cancer 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018

Press Mentions

  • Head-To-Head Trial Establishes T-DXd as Superior Second-Line Treatment for Some Gastric, GEJ Cancers
    Head-To-Head Trial Establishes T-DXd as Superior Second-Line Treatment for Some Gastric, GEJ CancersJune 3rd, 2025
  • Healthy Returns: AstraZeneca, Pfizer, Gilead and Other Drugmakers Release Promising Cancer Drug Data at ASCO
    Healthy Returns: AstraZeneca, Pfizer, Gilead and Other Drugmakers Release Promising Cancer Drug Data at ASCOJune 3rd, 2025
  • New Standard of Care in Triple-Negative Breast Cancer?
    New Standard of Care in Triple-Negative Breast Cancer?June 3rd, 2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Jane Meisel, Dr. Jane Meisel, MD, Dr. J Meisel, Dr. Jane Lowe Meisel